Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that the European urological device market was valued at nearly $500 million in 2005. According to the new report entitled European Markets for Urological Devices 2006, this market will be driven over the next 5 years by a growing home care market, an aging population, and a greater willingness on the part of patients to seek treatment for urological disorders.

The European prostate cancer device market, which includes high intensity focused ultrasound (HIFU), brachytherapy, and cryoablation, experienced notable growth in 2005 due in large part to the existence of reimbursement as well as long-term clinical data for HIFU treatment. The heightened success of HIFU devices in Europe in 2005 was also attributable to the innovative marketing efforts of dominant HIFU competitor EDAP-TMS. The company pioneered several innovative marketing strategies in Europe, including per-procedure payment options and increased access to the modality through mobile service providers, both of which have made this prostate cancer treatment option more popular.

MRG's European Markets for Urological Devices 2006 report is part of the Global Markets for Urological Devices series, which also includes analysis on the US and Japan. The series covers various key industry competitors, such as Coloplast A/S (COLO- B.KO), Mentor Corporation (MNT), Gynecare (JNJ), Bard Urological (BCR), Karl Storz, Hollister, AstraTech (AZN), AMS (AMMD), EDAP-TMS (EDAP), Olympus (OCPNY), Rusch (TFX), and Manfred Sauer.

About High Intensity Focused Ultrasounds

During HIFU, an ultrasound probe is inserted into the rectum and ultrasound beams are targeted at the prostate. The HIFU energy heats the prostate to the extent that prostate cells are killed and later discarded by the body.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:   Amy Krohn   Millennium Research Group   416-364-7776 x101 

SOURCE: Decision Resources, Inc.

CONTACT: Amy Krohn of Millennium Research Group, +1-416-364-7776 x101,

Blue Cross and Blue Shield of North Carolina Experienced Astonishing Growth in 2005

View Now